Journals / Okmeydanı Tıp Dergisi / 2015 / Cilt: 31 - Sayı: 0

Fundamentals of Metabolic Surgery, Nutritional Pathophysiology, İleal Proximalization Without "Functional Limitations" and Malabsorption

Metabolik Cerrahinin Temelleri, Beslenme Fizyopatolojisi, "Fonksiyonel Kısıtlama" ve Malabsorpsiyon Olmaksızın İleal Proksimalizasyon

Pages
82–85
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article has been written by evaluating the disease we try to treat and the compounds of this disease within causes-results relationship and with the purpose of guiding all healthcare professionals who prepare to embark upon metabolic surgery journey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metabolic surgery means the treatment of any metabolic disease by surgical means and, it is a broad specialization that covers obesity surgery as well.
📊
Key Findings & Data:In clinical practice, metabolic surgery means the surgical treatment of non-obese and overweight diabetic patients.
💡
Conclusion & Impact:This article has been written by evaluating the disease we try to treat and the compounds of this disease within causes-results relationship and with the purpose of guiding all healthcare professionals who prepare to embark upon metabolic surgery journey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Metabolic surgery means the treatment of any metabolic disease by surgical means and, it is a broad specialization that covers obesity surgery as well. In clinical practice, metabolic surgery means the surgical treatment of non-obese and overweight diabetic patients. In this respect, metabolic surgery differentiates from obesity surgery as it aims to establish blood sugar control. Because the main goal of obesity surgery is to achieve weight control, and sees blood sugar control merely as a side benefit. In any case and for any disease, it is imperative for the surgical community to harness surgical expertise and art with the accumulated knowledge about disease physiopathology and through this process, act with the consciousness of why and what he/ she is doing. This article has been written by evaluating the disease we try to treat and the compounds of this disease within causes-results relationship and with the purpose of guiding all healthcare professionals who prepare to embark upon metabolic surgery journey.

Özet

Metabolik cerrahi obezite ameliyatlarını da kapsayan geniş bir yelpaze olup, herhangi bir metabolik hastalığın cerrahi yöntemler kullanılarak tedavi edilmesi anlamına gelir. Klinik pratikte metabolik cerrahi dendiğinde akla gelen ise özellikle ciddi kilo sorunu olmayan diyabet hastalarında bu rahatsızlığın ameliyat yöntemleri kullanılarak tedavi edilmesidir. Bu bağlamda metabolik cerrahi temel hedefinin kan şekeri kontrolü olması nedeniyle obezite cerrahisinden ayrılır. Çünkü, obezite cerrahisinde temel hedef kilo kontrolü olup, kan şekeri bunun tali bir getirisidir. Cerrahi camianın her durumda ve her hastalıkta olduğu üzere cerrahi teknisyenliği ve buna ait sanatı hastalık fizyopatolojisine ait bilgi birikimi ile beraber harmanlayarak neyi neden yaptığı bilinci ile hareket etmesi gereklidir. Bu makale tedavi etmeye çalıştığımız hastalığı ve buna ait bileşenleri neden-sonuç ilişkisi içinde ele alarak metabolik cerrahi yolculuğuna çıkmaya hazırlanan tüm sağlık çalışanlarına yol gösterme amacı ile kaleme alınmıştır

🔖

Cite This Article

ÇELİK, A. (2015). Fundamentals of Metabolic Surgery, Nutritional Pathophysiology, İleal Proximalization Without "Functional Limitations" and Malabsorption. Okmeydanı Tıp Dergisi, Cilt: 31 - Sayı: 0, 82–85. https://ajindex.com/articles/291774

References (10)

  1. American Diabetes Association. The dangerous toll of diabetes. http://www.diabetes.org / diabetes -statistics/ dangerous-toll.jsp. 14.04.2015. Vaag AA. Glycemic control and prevention of mic- rovascular and macrovascular disease in the Steno 2 study. Endocr Pract 2006;12:89-92. http://dx.doi.org/10.4158/EP.12.S1.89
  2. Bermudez DM, Pories WJ. New technologies for trea- ting obesity. Minerva Endocrinol 2013;38:165-172. The Diabetes Prevention Program (DPP). Description of lifestyle intervention. Diabetes Care 2002;25(12): 2165-2171. http://dx.doi.org/10.2337/diacare.25.12.2165
  3. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014;370(21): 2002-2013. http://dx.doi.org/10.1056/NEJMoa1401329
  4. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic revi- ew and meta-analysis. Am J Med 2009;122:248-256. http://dx.doi.org/10.1016/j.amjmed.2008.09.041
  5. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009;150:94-103. http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00007
  6. Jenkins DJ, Wolever TM, Taylor RH, Ghafari H, Jen- kins AL, Barker H, et al. Rate of digestion of foods and postprandial glycaemia in normal and diabetic subjects. Br Med J 1980;281(6232):14-17. http://dx.doi.org/10.1136/bmj.281.6232.14
  7. Siegel EG, Creutzfeldt W. Stimulation of insulin rele- ase in isolated rat islets by GIP in physiological con- centrations and its relation to islet cyclic AMP content. Diabetologia 1985;28(11):857-861. http://dx.doi.org/10.1007/BF00291078
  8. Ross SA, Dupre J. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes 1978;27(3):327-333. http://dx.doi.org/10.2337/diab.27.3.327
  9. Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, et al. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetolo- gia 2003;46(6):798-801. http://dx.doi.org/10.1007/s00125-003-1103-y
  10. Santoro S, Castro LC, Velhote MCP, Malzoni CE, Klaj- ner S, Castro LP, et al. Sleeve gastrectomy with transit bipartition. A potent intervention for metabolic syndro- me and obesity. Ann Surg 2012;256:104-110. http://dx.doi.org/10.